Observational analysis shows decreased IAA levels in GmMYB14-OX soybean, suggesting a hormonal role in plant architecture.
In a previous study, GmMYB14 overexpressing (GmMYB14-OX) transgenic soybean plants displayed a semi-dwarfism and compact phenotype, which was regulated by the brassinosteroid (BR) pathway. However, the phenotype of GmMYB14-OX plants could be partly rescued after spraying them with exogenous BR. This indicates that other hormones, in addition to BR, also play a role in regulating the architecture of GmMYB14-OX plants. We observed a significant decrease in the content of endogenous indole-3-acetic acid (IAA) in transgenic soybean lines (OX9 and OX12) compared to wild type (WT) plants. The plant height, leaf area, leaf petiole length, and leaf petiole angle of GmMYB14-OX plants could also be partly rescued after applying exogenous IAA for two weeks. Transcriptome sequencing analysis revealed that the expression of many genes within the Aux/IAA gene family underwent alterations in the GmMYB14-OX transgenic soybean plants. Among them, Glyma.02G000500 (GmIAA1) showed the highest expression in GmMYB14-OX plants. Furthermore, the results of electrophoretic mobility shift assay and dual-luciferase reporter indicate that GmMYB14 protein could bind to the promoter of GmIAA1. In summary, a decrease in endogenous IAA content may be one of the factors contributing to the compact and dwarfed architecture of GmMYB14-OX plants. GmMYB14 also acts as a transcriptional activator of GmIAA1 to potentially block IAA effects. Our findings provide a theoretical basis for further investigation of the regulatory mechanism of GmMYB14 on soybean plant architecture.
No takes yet. Share an insight, caveat, or question.
Peng et al. (2025) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: